VANFLYTA cpr pell 26.5 mg 56 pce
7680697100059
CH-69710
L01EX11
07.16.1.
1 / 3
google
Details
- Product number
- 6971002
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- quizartinibi dihydrochloridum 30 mg corresp. quizartinibum 26.5 mg, hydroxypropylbetadexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, talcum, triacetinum, E 171, E 172 (flavum), pro compresso obducto.
Articles (1)
VANFLYTA 26.5 mg, Filmtabletten
Filmtabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | WIZUS |
|
(N/A)
|
26.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
Authorization holder
Daiichi Sankyo (Schweiz) AG
8048 Zürich
Authorization information
- Swissmedic authorization number
- 69710
- Drug name
- VANFLYTA, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EX11
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 31/03/2025
- Authorization expiration date
- 30/03/2030
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VANFLYTA cpr pell 26.5 mg 56 pce
- Description (DE)
- VANFLYTA Filmtabl 26.5 mg 56 Stk
- Market launch
- 31/03/2025
- Narcotic (BTM)
- No